Table 2.
Allogeneic (Allo) | Autologous (Auto) | Total | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Donors | Unrelated Donors | ||||||||||||||||
HLA id sibling | Other relative | Total | Total | Allo | Auto | Total Allo + Auto | |||||||||||
Indication for transplant | BM* | PB^ | CB# | BM | PB | CB | BM | PB | CB | BM | PB | CB | |||||
Total | 957 | 165 | 30 | 185 | 128 | 10 | 1475 | 1236 | 490 | 1207 | 2933 | 49 | 3024 | 3 | 4408 | 3076 | 7484 |
Leukemia | 910 | 135 | 29 | 168 | 117 | 10 | 1369 | 1177 | 455 | 1169 | 2801 | 2 | 16 | 0 | 4170 | 18 | 4188 |
AML& | 323 | 46 | 11 | 56 | 39 | 3 | 478 | 413 | 178 | 447 | 1038 | 2 | 15 | 0 | 1516 | 17 | 1533 |
ALL@ | 456 | 57 | 15 | 85 | 58 | 3 | 674 | 493 | 203 | 526 | 1222 | 0 | 1 | 0 | 1896 | 1 | 1897 |
CML+ | 45 | 10 | 2 | 8 | 2 | 1 | 68 | 97 | 20 | 65 | 182 | 0 | 0 | 0 | 250 | 0 | 250 |
Bi-phenotypic leukemia | 25 | 8 | 0 | 7 | 8 | 0 | 48 | 25 | 8 | 37 | 70 | 0 | 0 | 0 | 118 | 0 | 118 |
MPN%/MDS$ | 56 | 13 | 1 | 12 | 8 | 3 | 93 | 139 | 45 | 86 | 270 | 0 | 0 | 0 | 363 | 0 | 363 |
Other leukemias | 5 | 1 | 0 | 0 | 2 | 0 | 8 | 10 | 1 | 8 | 19 | 0 | 0 | 0 | 27 | 0 | 27 |
Lymphoma | 44 | 25 | 1 | 13 | 9 | 0 | 92 | 57 | 32 | 36 | 125 | 11 | 495 | 0 | 217 | 506 | 723 |
Hodgkin lymphoma | 5 | 5 | 0 | 4 | 2 | 0 | 16 | 11 | 6 | 0 | 17 | 5 | 396 | 0 | 33 | 401 | 434 |
Non-Hodgkin lymphoma | 39 | 20 | 1 | 9 | 7 | 0 | 76 | 46 | 26 | 36 | 108 | 6 | 99 | 0 | 184 | 105 | 289 |
Plasma cell disorder | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 5 | 0 | 2 | 5 | 7 |
Solid tumors | 3 | 4 | 0 | 4 | 2 | 0 | 13 | 1 | 3 | 2 | 6 | 36 | 2508 | 3 | 19 | 2547 | 2566 |
Medulloblastoma | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 11 | 377 | 1 | 2 | 389 | 391 |
Other CNS tumors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 395 | 1 | 0 | 409 | 409 |
Neuroblastoma | 1 | 2 | 0 | 1 | 0 | 0 | 4 | 0 | 0 | 1 | 1 | 4 | 1333 | 1 | 5 | 1338 | 1343 |
Ewing family tumors | 1 | 1 | 0 | 0 | 2 | 0 | 4 | 0 | 2 | 1 | 3 | 2 | 127 | 0 | 7 | 129 | 136 |
Retinoblastoma | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 32 | 0 | 0 | 35 | 35 |
Germ cell tumors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68 | 0 | 0 | 68 | 68 |
Wilms tumor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 68 | 0 | 0 | 70 | 70 |
Gonadal tumors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 44 | 0 | 0 | 45 | 45 |
Rhabdomyo sarcoma | 0 | 1 | 0 | 2 | 0 | 0 | 3 | 0 | 1 | 0 | 1 | 0 | 17 | 0 | 4 | 17 | 21 |
Other solid tumors | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | 1 | 47 | 48 |
Acute myeloid leukemia,
Acute lymphoblastic leukemia,
Chronic myeloid leukemia,
Myeloproliferative neoplasm,
Myelodysplastic syndrome,
Bone marrow,
Peripheral blood stem cells,
Cord blood